On Monday, Shares of Opko Health, Inc. (NYSE:OPK), gained 3.51% to $16.82.
OPKO Health, and Bio-Reference Laboratories, Inc. (BRLI), declared that early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) has been granted, effective July 1, 2015, for OPKO’s planned acquisition of Bio-Reference.
Expiration of the waiting period under the HSR Act satisfies one of the conditions necessary for the consummation of the merger. The transaction remains subject to other closing conditions, counting the approval of Bio-Reference shareholders. The parties continue to expect that this transaction will close during the second half of 2015.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics.
Shares of MetLife, Inc. (NYSE:MET), declined -0.45% to $55.91, during its last trading session.
MetLife, declared the final results of the tender offer for its 6.500% Non-Cumulative Preferred Stock, Series B (CUSIP No. 59156R603), par value $0.01 per share and liquidation preference $25.00 per share (the “Series B Preferred Shares”), which expired at 12:00 midnight, New York City time, on June 26, 2015. The Series B Preferred Shares are listed on the NYSE under the symbol “METPrB.”
A total of 37,192,413 Series B Preferred Shares were properly tendered and not properly withdrawn.
MetLife, Inc. provides life insurance, annuities, employee benefits, and asset administration products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa.
Finally, Schnitzer Steel Industries, Inc. (NASDAQ:SCHN), ended its last trade with 0.87% gain, and closed at $19.75.
Schnitzer Steel Industries, stated financial results for its fiscal 2015 third quarter ended May 31, 2015.
Merged Financial Performance
The Company declared break-even adjusted earnings per share from ongoing operations for the third quarter, which compares to second quarter adjusted loss per share of $0.30 and preceding year third quarter adjusted earnings per share of $0.19. Adjustments comprised of charges for restructuring and exit-related costs and asset impairments. Third quarter adjusted results comprised of an adverse impact from average inventory accounting of about $0.40 per share which compares to a second quarter adverse impact of $0.36 per share and a preceding year third quarter adverse impact of $0.09 per share. Based on current market trends, estimated adverse inventory effects are predictable to be substantially reduced in the fourth quarter.
The Company stated third quarter loss per share from ongoing operations of $0.31, counting $6 million in restructuring and exit-related costs and $1 million in asset impairments. This compares to the second quarter stated loss per share of $7.08 and third quarter fiscal 2014 stated earnings per share of $0.13.
Schnitzer Steel Industries, Inc. manufactures and exports recycled ferrous metal products worldwide. The company operates in three segments: Metals Recycling Business (MRB), Auto Parts Business (APB), and Steel Manufacturing Business (SMB).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
